Manoj Kesarwani is a Cardiology physician affiliated with University of California, Davis. OpenAlex indexes 27 publications with 319 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4860 Y St
Suite 2820
Sacramento, CA 958172307
Telephone
916-734-5191Registry record last updated 20 Mar 2017.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Philips North America LLCProgram year202516 payments
- Medtronic, Inc.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.6%Statin20.5%Rosuvastatin Calcium50%Atorvastatin Calcium50%Part D≥27 patientsBeta blocker17.3%Metoprolol Succinate48%Metoprolol Tartrate33%Carvedilol19%Part D≥19 patients+ 8 more classes in this area
Blood & clotting
22.8%P2Y12 inhibitor11.4%Clopidogrel53%Brilinta47%Part D≥16 patientsFactor Xa inhibitor8.9%Eliquis100%Part D≥19 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.6%SGLT2 inhibitor1.6%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expert perspectives on de-escalation of antiplatelet therapy – Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting
Cardiovascular revascularization medicine
2026 - Current Evidence-Based Treatment of Angina With Nonobstructive Coronary Arteries (ANOCA)
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - After PCI for ACS or stable CAD, DAPT for 1 mo vs. >1 mo reduces major bleeding without increasing stent thrombosis
Annals of Internal Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ezra Amsterdam, MD
University of California, Davis
Michael Rogawski, MD
University of California, Davis
Christopher Bowlus, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”